Surveillance Study of NovoRapid® for New Drug Re-examination
Status:
Completed
Trial end date:
2006-06-01
Target enrollment:
Participant gender:
Summary
This study is conducted in Asia. The aim of this study is to observe the safety and efficacy
of insulin aspart (NovoRapid®) administered via vial and three different devices.